Literature DB >> 24291763

Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.

Mona M Mohamed1, Eslam A El-Ghonaimy2, Mohamed A Nouh3, Robert J Schneider4, Bonnie F Sloane5, Mohamed El-Shinawi6.   

Abstract

Although there is a growing literature describing the role of macrophages in breast cancer, the role of macrophages in inflammatory breast cancer (IBC) is unclear. The aim of present study was to isolate and characterize tumor associated macrophages of IBC and non-IBC patients and define their role in IBC. Tumor infiltrating monocytes/macrophages (CD14+ and CD68+) were measured by immunohistochemistry using specific monoclonal antibodies. Blood drained from axillary vein tributaries was collected during breast cancer surgery and the percentage of CD14+ in the total isolated leukocytes was assessed by flow cytometric analysis. CD14+ cells were separated from total leukocytes by immuno-magnetic beads technique and were cultured overnight. Media conditioned by CD14+ were collected and subjected to cytokine profiling using cytokine antibody array. Wound healing and invasion assays were used to test whether cytokines highly secreted by tumor drained macrophages induce motility and invasion of breast cancer cells. We found that macrophages highly infiltrate into carcinoma tissues of IBC patients. In addition blood collected from axillary tributaries of IBC patients is highly enriched with CD14+ cells as compared to blood collected from non-IBC patients. Cytokine profiling of CD14+ cells isolated from IBC patients revealed a significant increase in secretion of tumor necrosis factor-α; monocyte chemoattractant protein-1/CC-chemokine ligand 2; interleukin-8 and interleukin-10 as compared to CD14+ cells isolated from non-IBC patients. Tumor necrosis factor-α, interleukin-8 and interleukin-10 significantly increased motility and invasion of IBC cells in vitro. In conclusion, macrophages isolated from the tumor microenvironment of IBC patients secrete chemotactic cytokines that may augment dissemination and metastasis of IBC carcinoma cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-C chemokine receptor type 2; CC-chemokines ligand 2; CCL-2; CCR2; Cytokines; HCMV; IBC; IL-10; IL-13; IL-4; IL-8; INF-γ; Inflammatory breast cancer; Invasion; M1; M2; MCP-1; MMP-2; MMP-9; Macrophages; Motility; NF-κB; Nuclear factor kappa beta; PI3K; STAT3; TAMs; TNF-α; alternatively activated macrophages; c-Fms; classical activated macrophages; human cytomegalovirus; inflammatory breast cancer; interferon-γ; interleukin- 8; interleukin-10; interleukin-13; interleukin-4; macrophage colony stimulating factor-1 receptor; matrix metalloproteinases-2; matrix metalloproteinases-9; monocyte chemoattractant protein-1; phosphatidylinositol-3 kinas; signal transducer and activator of transcription; tumor associated macrophages; tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2013        PMID: 24291763      PMCID: PMC3928544          DOI: 10.1016/j.biocel.2013.11.015

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  67 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 2.  Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.

Authors:  Rita A Mukhtar; Onouwem Nseyo; Michael J Campbell; Laura J Esserman
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

3.  Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

Authors:  Andrea L Dewar; Antony C Cambareri; Andrew C W Zannettino; Bernadette L Miller; Kathleen V Doherty; Timothy P Hughes; A Bruce Lyons
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

4.  Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

Authors:  Steven J Van Laere; Gert G Van den Eynden; Ilse Van der Auwera; Melanie Vandenberghe; Peter van Dam; Eric A Van Marck; Kenneth L van Golen; Peter B Vermeulen; Luc Y Dirix
Journal:  Breast Cancer Res Treat       Date:  2005-10-27       Impact factor: 4.872

5.  Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy.

Authors:  Mikala Egeblad; Andrew J Ewald; Hanne A Askautrud; Morgan L Truitt; Bryan E Welm; Emma Bainbridge; George Peeters; Matthew F Krummel; Zena Werb
Journal:  Dis Model Mech       Date:  2008-09-18       Impact factor: 5.758

6.  Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.

Authors:  L Kozłowski; I Zakrzewska; P Tokajuk; M Z Wojtukiewicz
Journal:  Rocz Akad Med Bialymst       Date:  2003

7.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

8.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.

Authors:  Jeffrey B Wyckoff; Yarong Wang; Elaine Y Lin; Jiu-feng Li; Sumanta Goswami; E Richard Stanley; Jeffrey E Segall; Jeffrey W Pollard; John Condeelis
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

Review 9.  Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype.

Authors:  Yun Gong
Journal:  Semin Oncol       Date:  2008-02       Impact factor: 4.929

10.  Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.

Authors:  Mohamed El-Shinawi; Hossam Taha Mohamed; Eslam A El-Ghonaimy; Marwa Tantawy; Amal Younis; Robert J Schneider; Mona Mostafa Mohamed
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more
  42 in total

1.  A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis.

Authors:  Susan Tsai; Laura McOlash; Shuang Jia; Jian Zhang; Pippa Simpson; Mary L Kaldunski; Mohammed Aldakkak; Jenny Grewal; Katie Palen; Michael B Dwinell; Bryon D Johnson; Alexander Mackinnon; Martin J Hessner; Jill A Gershan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-12-07       Impact factor: 4.254

2.  Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated.

Authors:  Takashi Muraki; Michelle D Reid; Olca Basturk; Kee-Taek Jang; Gabriela Bedolla; Pelin Bagci; Pardeep Mittal; Bahar Memis; Nora Katabi; Sudeshna Bandyopadhyay; Juan M Sarmiento; Alyssa Krasinskas; David S Klimstra; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2016-09       Impact factor: 6.394

3.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

4.  Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.

Authors:  Eslam A Elghonaimy; Sherif A Ibrahim; Amal Youns; Zeinab Hussein; Mohamed Akram Nouh; Tahani El-Mamlouk; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Tumour Biol       Date:  2016-06-22

5.  Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.

Authors:  Marta Alonso-Nocelo; Theresa M Raimondo; Kyle H Vining; Rafael López-López; Maria de la Fuente; David J Mooney
Journal:  Biofabrication       Date:  2018-03-28       Impact factor: 9.954

6.  Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of κB Kinase ϵ and Inflammatory Cross-talk with Macrophages.

Authors:  Brian J Girard; Todd P Knutson; Bethanie Kuker; Laura McDowell; Kathryn L Schwertfeger; Julie H Ostrander
Journal:  J Biol Chem       Date:  2016-11-23       Impact factor: 5.157

7.  Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.

Authors:  Amanda Valeta-Magara; Abhilash Gadi; Viviana Volta; Beth Walters; Rezina Arju; Shah Giashuddin; Hua Zhong; Robert J Schneider
Journal:  Cancer Res       Date:  2019-05-01       Impact factor: 12.701

8.  The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.

Authors:  Ivette J Suárez-Arroyo; Yismeilin R Feliz-Mosquea; Juliana Pérez-Laspiur; Rezina Arju; Shah Giashuddin; Gerónimo Maldonado-Martínez; Luis A Cubano; Robert J Schneider; Michelle M Martínez-Montemayor
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

9.  Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.

Authors:  Komal Jhaveri; Eleonora Teplinsky; Deborah Silvera; Amanda Valeta-Magara; Rezina Arju; Shah Giashuddin; Yasmeen Sarfraz; Melissa Alexander; Farbod Darvishian; Paul H Levine; Salman Hashmi; Ladan Zolfaghari; Heather J Hoffman; Baljit Singh; Judith D Goldberg; Tsivia Hochman; Silvia Formenti; Francisco J Esteva; Meena S Moran; Robert J Schneider
Journal:  Clin Breast Cancer       Date:  2015-12-01       Impact factor: 3.225

Review 10.  Slit/Robo pathway: a promising therapeutic target for cancer.

Authors:  Rishi K Gara; Sonam Kumari; Aditya Ganju; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2014-09-20       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.